Author correction to “The upregulated intestinal folate transporters direct the uptake of ligand-modified nanoparticles for enhanced oral insulin delivery” [Acta Pharm Sin B 12 (2022) 1460–1472]
aSchool of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China
bState Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
cUniversity of Chinese Academy of Sciences, Beijing 100049, China
dOral Formulation Development, Novo Nordisk A/S, Maalov 2760, Denmark
eDepartment of Pharmacy, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen 2100, Denmark
fUniversity of Texas at Dallas, Richardson, TX 75080, USA
gNMPA Key Laboratory for Quality Research and Evaluation of Pharmaceutical Excipients, National Institutes for Food and Drug Control, Beijing 100050, China
* Corresponding authors. Tel.:+86 021 51322181, fax:+86 021 51322193 (Rui Wang)
Tel.:+01 972 883 4480, fax:+01 972 883 4440 (Xiuying Li)
Tel.:+86 021 20231975, fax:+86 021 20231000 1425 (Yong Gan)
收起